Captrust Financial Advisors Fulgent Genetics, Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$47.98 - $62.75 $3,358 - $4,392	-70 Reduced 7.42%	873 $48,000
Q2 2022 Aug 16, 2022	BUY	$47.98 - $62.75 $7,196 - $9,412	150 Added 18.92%	943 $51,000
Q1 2022 May 16, 2022	SELL	$49.85 - $96.11 $60,567 - $116,773	-1,215 Reduced 60.51%	793 $49,000
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $25,045 - $34,020	-324 Reduced 13.89%	2,008 $202,000
Q3 2021 Nov 16, 2021	BUY	$74.87 - $110.87 $66,784 - $98,896	892 Added 61.94%	2,332 $210,000
Q2 2021 Aug 16, 2021	BUY	$66.8 - $100.45 $25,050 - $37,668	375 Added 35.21%	1,440 $133,000
Q1 2021 May 17, 2021	BUY	$59.3 - $183.85 $15,536 - $48,168	262 Added 32.63%	1,065 $103,000
Q4 2020 Feb 16, 2021	BUY	$31.01 - $52.1 $24,187 - $40,638	780 Added 3391.3%	803 $42,000
Q3 2020 Nov 17, 2020	SELL	$15.89 - $50.51 $31,414 - $99,858	-1,977 Reduced 98.85%	23 $1,000
Q2 2020 Aug 14, 2020	BUY	$8.89 - $18.28 $17,780 - $36,560	2,000 New	2,000 $32,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.